NCT00791401View on ClinicalTrials.gov

A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

February 28, 2005

Conditions
SchizophreniaRenal Impairment
Interventions
DRUG

ER OROS Paliperidone

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00791401 - A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function | Biotech Hunter | Biotech Hunter